Sten Olsson
Impact in
- Toxicology top 0.02%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 34
- Pharmacovigilance and Adverse Drug Reactions 34
-
- Pharmaceutical Economics and Policy 14
- Co-authors
- Shanthi Pal (11 shared papers)Marie Lindquist (3 shared papers)I. Ralph Edwards (4 shared papers)Andrew Bate (2 shared papers)Roland Orre (1 shared paper)Anders Lansner (1 shared paper)Rivelilson Mendes de Freitas (1 shared paper)Mary Couper (2 shared papers)
- Journals
- Drug Safety (16 papers)Malaria Journal (3 papers)The Lancet (2 papers)Value in Health (2 papers)Pharmacoepidemiology and Drug Safety (2 papers)
- Partner nations
- SwedenSwitzerlandNetherlands
In The Last Decade
Sten Olsson
56 papers receiving 2.6k citations
Sten Olsson's Hit Papers
Peers
Comparison fields: 5 of 139
- Toxicology 1.5k
- Geriatrics and Gerontology 148
- Applied Microbiology and Biotechnology 35
- Pharmacology 256
- Pharmacology 136
Countries citing papers authored by Sten Olsson
This map shows the geographic impact of Sten Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sten Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sten Olsson more than expected).
Fields of papers citing papers by Sten Olsson
This network shows the impact of papers produced by Sten Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sten Olsson. The network helps show where Sten Olsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Sten Olsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Bayesian neural network method for adverse drug reaction signal generation Hit paper breakdown → | 1998 | 1054 |
| 2 | 2013 | 182 | |
| 3 | 2003 | 143 | |
| 4 | 2010 | 141 | |
| 5 | 2016 | 126 | |
| 6 | 1998 | 120 | |
| 7 | 2011 | 117 | |
| 8 | 2015 | 116 | |
| 9 | 2011 | 71 | |
| 10 | 2021 | 63 | |
| 11 | 2020 | 56 | |
| 12 | 1978 | 49 | |
| 13 | 2020 | 44 | |
| 14 | 1989 | 42 | |
| 15 | 2014 | 39 | |
| 16 | 2006 | 33 | |
| 17 | 2011 | 31 | |
| 18 | 2015 | 31 | |
| 19 | 2014 | 26 | |
| 20 | 1994 | 23 |
About Sten Olsson
Sten Olsson is a scholar working on Toxicology, Economics and Econometrics, Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 56 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (34 papers), Pharmaceutical Economics and Policy (14 papers), Drug-Induced Adverse Reactions (8 papers), Computational Drug Discovery Methods (5 papers), Tuberculosis Research and Epidemiology (5 papers), Pharmaceutical studies and practices (5 papers), Pharmaceutical Quality and Counterfeiting (4 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Toxicology (1.5k citations), Geriatrics and Gerontology (148 citations), Applied Microbiology and Biotechnology (35 citations), Pharmacology (256 citations) and Pharmacology (136 citations). Sten Olsson has collaborated with scholars based in Sweden, Switzerland and Netherlands. Frequent co-authors include Shanthi Pal, Marie Lindquist, I. Ralph Edwards, Andrew Bate, Roland Orre, Anders Lansner, Rivelilson Mendes de Freitas, Mary Couper, Kees van Grootheest and Chris Duncombe. Their work appears in journals such as Drug Safety, Malaria Journal, The Lancet, Value in Health and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.